 Connection
Ashley Brooks-Russell to Dronabinol
This is a "connection" page, showing publications Ashley Brooks-Russell has written about Dronabinol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.713 |
|
|
|
-
Kosnett MJ, Ma M, Dooley G, Wang GS, Friedman K, Brown T, Henthorn TK, Brooks-Russell A. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):355-362.
Score: 0.194
-
Arkell TR, Brooks-Russell A, Downey LA, Shiferaw B, Brown T, Sherrick J, Hayley AC. Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review. Neurosci Biobehav Rev. 2022 10; 141:104831.
Score: 0.185
-
Brooks-Russell A, Brown T, Friedman K, Wrobel J, Schwarz J, Dooley G, Ryall KA, Steinhart B, Amioka E, Milavetz G, Sam Wang G, Kosnett MJ. Simulated driving performance among daily and occasional cannabis users. Accid Anal Prev. 2021 Sep; 160:106326.
Score: 0.173
-
Wood E, Brooks-Russell A, Drum P. Delays in DUI blood testing: Impact on cannabis DUI assessments. Traffic Inj Prev. 2016; 17(2):105-8.
Score: 0.112
-
Rague JM, Ma M, Dooley G, Wang GS, Friedman K, Henthorn TK, Brooks-Russell A, Kosnett MJ. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):363-369.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|